Enzo Biochem, Inc. (ENZ) – Dylan Marrello
Pitch Summary: @ragingbullcap believes Enzo is deeply undervalued after OTC-driven selling despite holding large cash reserves, valuable real estate, NOLs, and an operating unit with strong gross margins. The author thinks strategic alternatives—including a potential sale of ELS and redeployment of capital into an NOL-utilizing business—could unlock significant value. Risks remain, but the balance sheet […]
